MedPath

Resistance-aerobic training in beta thalassemia major patients

Phase 2
Conditions
Patient with beta thalassemia major.
Beta thalassemia
Registration Number
IRCT20150531022498N19
Lead Sponsor
Islamic Azad University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Have beta thalassemia major disease
Have regular blood transfusion
19–25 years using of Desferal

Exclusion Criteria

Absence for more than three exercise sessions
Have acute heart disease
Musculoskeletal abnormalities or any other medical condition that can contribute to exercise limitation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiovascular index. Timepoint: Before and 24 hours after the end of intervention. Method of measurement: Using by measuring heart rate, QTc distance, end systolic volume, end diastolic volume and ejection fraction.;Quality of life. Timepoint: Before and after the end of intervention. Method of measurement: Using by quality of life questionnaire (SF-36).
Secondary Outcome Measures
NameTimeMethod
Body composition. Timepoint: Before and after the end of intervention. Method of measurement: Using by measuring body mass index and fat percent.;Physical fitness. Timepoint: Before and after the end of intervention. Method of measurement: Using by measuring maximum oxygen consumption (VO2max) and muscle endurance.
© Copyright 2025. All Rights Reserved by MedPath